BVM Capital

BVM Capital LLC is a Louisiana-based venture capital and private equity firm that specializes in early-stage investments primarily in life sciences, healthcare, technology, agriculture, biotechnology, and pharmaceuticals. Founded in 2000, the firm focuses its investments in the Southeast, particularly Louisiana, and typically commits between $0.1 million and $3 million to companies at various stages of development, including seed, early, mid, and late venture, as well as expansion and growth stages. BVM Capital often seeks a board seat in its portfolio companies and prefers to co-invest when not leading a round. The firm generally holds its investments for three to seven years, aiming for exits through mergers, acquisitions, or initial public offerings. While headquartered in Bossier City, Louisiana, BVM Capital also maintains offices in New York City and New Orleans.

http://www.bvmcap.com

https://crunchbase.com/organization/bvm-capital

https://pitchbook.com/profiles/investor/52370-83

https://twitter.com/bodyimage

https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=12149466

https://www.privateequityinternational.com/database/#/profile?id=7941

Ross Barrett

Founder and Managing Partner

7 past transactions

FIX Health

Seed Round in 2012

FIX Health develops high quality, interactive games that promote health and daily activity in a fun. FIX is dedicated to making fitness fun, accessible and hyper-socially connected through an interactive social media platform centered around making the pursuit of fitness an enjoyable and engaging game.

NuMe Health

Series A in 2011

NuMe Health is a biotechnology company focused on medical foods for the special dietary requirements associated with major chronic diseases including: cancer, obesity, and diabetes.

Microbiome Therapeutics

Seed Round in 2013

MicroBiome Therapeutics is a biotechnology company that develops medical food and pharmaceutical products. The company focuses on developing evidence-based microbiome modulators, which are designed to alter bacteria populations and their environment in the gastrointestinal tract in specific ways to treat and prevent serious health conditions. Its product includes NM504, which contains a combination of prebiotic and other naturally occurring ingredients formulated to help diabetic individuals achieve healthy blood glucose levels and manage their body weight. MicroBiome Therapeutics was formerly known as NuMe Health LLC. The company was founded in 2009 and is based in Broomfield, Colorado.

Embera NeuroTherapeutics

Series A in 2015

Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

K94 Discoveries

Seed Round in 2013

K94 Discoveries, Inc. operates as a biotechnology company and develops anticancer drugs based on discoveries by scientists at LSU’s Pennington Biomedical Research Institute and Feist Weiller Cancer Center. The company is based in the United States.

Calosyn Pharma

Seed Round in 2009

CaloSyn Pharma, Inc., a biopharmaceutical company, develops intra-articular therapeutics for osteoarthritis. It develops drugs, which is known as calcium channel blockers for osteoarthritis. These drugs used in the treatment of heart and vascular diseases. Its therapeutic approach is based on combinations of ion channel modulators, which block the synthesis of the enzymes responsible for cartilage destruction. The company was founded in 2007 and is based in Boston, Massachusetts with additional offices in Shreveport, Louisiana and Atlanta, Georgia.

NuMe Health

Series A in 2012

NuMe Health is a biotechnology company focused on medical foods for the special dietary requirements associated with major chronic diseases including: cancer, obesity, and diabetes.